Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07002580

Evaluation of the Effectiveness of iPACK and Adductor Canal Blocks on Patients Undergoing Arthroscopic Knee Surgery

Arthroscopic knee surgery is one of the most commonly performed procedures in orthopedic surgery. More than 50% of patients experience moderate to severe pain after the operation. Inadequate postoperative pain control and poor recovery quality can negatively impact physiotherapy protocols, prolong hospital stays, and consequently lead to cognitive dysfunction, systemic infections, and increased healthcare costs.

Therefore, reducing postoperative pain and improving recovery quality are of great importance. In our clinic, a variety of analgesic techniques are routinely employed as part of a multimodal analgesia approach for patients undergoing arthroscopic knee surgery. One of these techniques is the simultaneous application of the IPACK block and the adductor canal block.

In this study, we aim to evaluate the effectiveness of these blocks on postoperative recovery quality in patients undergoing arthroscopic knee surgery.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sakarya University Training and Research Hospital

Sakarya, Turkey (Türkiye)

Location status: Recruiting

Location contact

Oğuzhan Okumuş, M.D.

CONTACT

[email protected]

+905372093019

Oğuzhan Okumuş, M.D.

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged between 18 and 50 years,
  • Scheduled for arthroscopic knee surgery under spinal anesthesia due to knee pathology
  • Patients classified as ASA physical status I-II-III according to the American Society of Anesthesiologists risk classification

Exclusion criteria

  • Coagulopathy
  • ASA IV-V patients
  • Uncooperable patients
  • Patients who refuses to participate in study
  • Patients who takes chronic pain treatments

Treatment and study plan

IPACK and adductor canal block with Bupivacaine 0.25%

Procedure

iPACK block is infiltration between the Popliteal Artery and the Capsule of the Knee. iPACK and adductor canal blocks are performed with ultrasound guidence under sterile conditions.

Spinal Anesthesia with Bupivacaine

Procedure

Spinal Anesthesia is a basic anesthesia method used for years to grant anesthesia for surgeries for lower extremities and lower torso surgeries.

Primary outcomes

  1. Quality of Recovery

    Time frame: 24 hours.

    Quality of Recovery of the patients will be assessed with QoR-15 questionnaire. Its scoring will range between 0 and 150 points.

Secondary outcomes

  1. Analgesic Consumption

    Time frame: 24 hours.

    The total analgesic consumption of patients according to the patient controlled analgesia device which measures the opioid consumption for 24 hours.

Study contacts

Contact information is provided by the study sponsor or research team.

Oğuzhan Okumuş, M.D.

CONTACT

[email protected]

+905372093019

Sponsors and collaborators

Lead sponsor

Sakarya University

Other

Registry information

Official study title

Evaluation of the Effectiveness of iPACK (Local Anesthetic Infiltration of the Interspace Between the Popliteal Artery and the Posterior Knee Capsule) and Adductor Canal Blocks on Quality of Recovery in Patients Undergoing Arthroscopic Knee Surgery

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jun 3, 2025
Registry last updated
Feb 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.